Dennis Ford of Life Science Nation shared tips on interacting with investors as you work on a strategic method of fundraising for your R&D.

View Slide Deck

John Nobile of Tangen Biosciences talked about his company’s process in achieving their recent contract with BARDA.

Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.

View Slide Deck

Dr. Natalie Wisniewski, of Profusa, Inc., gave some insight about her company’s non-dilutive funding journey, starting with their initial grant from DARPA in 2011 through to today.

Dr. James B. Phillips of USAMRMC, Department of Defense, shared with the audience the mission of the US Army Medical Research and Material Command and the Medical Technology Enterprise Consortium, discussing opportunities available for partnering and engaging with Industry.

View Slide Deck

Ram May-Ron, Managing Partner of the FreeMind Group, opened the 13th Annual Non-Dilutive Funding Summit with a few comments on the value of non-dilutive funding to the life sciences industry.

FreeMind Group is happy to support Biotech Showcase 2018!

Where: San Francisco, CA
When: January 8-10, 2018

  • This exclusive biotech investor conference is taking place during healthcare’s most important week
  • Meet 3,500+ C-level executives including 900+ Investors
  • More than $334 billion in capital represented
  • 400 public and private company presentations
  • Panels and sessions, including top industry leaders
  • Preschedule one-to-one investor and partnering meetings


Biotech Showcase 2018 | January 8–10 | San Francisco, California

FreeMind is pleased to support the upcoming Life Sciences Summit!

Where: New York City, NY
When: November 1-2, 2017

The Life Sciences Summit is an early-stage investor and business development conference for emerging companies and academic innovators. The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, and medical research foundations with the goal of advancing new innovations through clinical development.

The Summit provides emerging companies and academic innovators with exposure to potential investors and strategic partners through

  • Emerging Company Showcase
  • Pitch Doctor Sessions
  • Pipeline Café
  • Business Workshops & Plenary Sessions
  • Therapeutic Focused Panels
  • Online & Onsite Partnering
  • Strategic Partners Presentations

The Life Sciences Summit is the premier meeting dedicated to bringing emerging companies and innovators together with capital and industry in a setting that facilitates collaboration and networking.

Visit to learn more.

FreeMind Group is proud to support BioFIT 2017!

Where: Strasbourg, France
When: November 28-29, 2017

As you may know, the 6th edition of BioFIT will take place on 28th and 29th November in Strasbourg. BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovation and seed investment in the field of Life Sciences. With more than 1,200 international leading actors from 35+ countries, the event gathers big pharma, emerging and small biotech companies, pre-seed/seed/Series A investors, as well as professionals from tech transfer, academia and research institutions.

Many key players have already confirmed their presence, including Pfizer, AbbVie, J&J, Sanofi, Roche, GSK, Novo Nordisk, Pierre Fabre, AstraZeneca, Lilly, Bayer, Merck, Servier, Janssen Pharmaceutica, Evotec, Lonza, Ipsen, Boehringer Ingelheim, Genfit, Transgene, Sofinnova Partners, Onxeo, Debiopharm, Kurma Partners, VIB, Novo Seeds, European Investment Fund, Max Planck Institute, MRC Technology, Ascenion, Isis Innovation…

Discover the list of participants
Download the programme

Use our network code BF17_FREEMINDS% for a 25% discount!

Register for BioFIT